CVintra # CVinter # CVtotal [Regulatives / Guidelines]

posted by Helmut Homepage – Vienna, Austria, 2008-11-20 12:18 (6414 d 08:05 ago) – Posting: # 2747
Views: 9,267

Dear Muneesh,

❝ I donot understand what do you mean by replicated dosing in the parallel arms to get the CV.


If you want to plan the sample size for a cross-over study you need the intra-subject variability (CVintra). If you have dosed both treatments only once per subject (nonreplicate) in a parallel design, you only have the total variability (CVtotal). See this post (you may have found it searching the forum as DLabes suggested already).

❝ And in another pilot study with parallel design for long half-life drug, subjects were dosed only once in the study.


OK, you are talking about the same drug hopefully? You have one cross-over pilot and one parallel and now want to plan a pivotal cross-over? From the cross-over study you may get a relationship of CVintra and CVtotal, which you may apply to the parallel getting another estimate of CVintra. You may pool these two CVintra-values - but this is some kind of vicious circle;-)

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,653 posts in 4,991 threads, 1,570 registered users;
100 visitors (0 registered, 100 guests [including 16 identified bots]).
Forum time: 21:24 CEST (Europe/Vienna)

To propose that poor design can be corrected by subtle analysis techniques
is contrary to good scientific thinking.    Stuart J. Pocock

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5